| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |